期刊文献+

呼吸机相关性肺炎的病原菌及耐药性分析 被引量:6

Distribution and drug-resistance of pathogens in patients with ventilator-associated pneumonia
原文传递
导出
摘要 目的研究重症监护病房(ICU)内呼吸机相关性肺炎(VAP)的病原菌分布及其耐药性,为临床用药提供参考。方法以我院2007年12月~2008年12月ICU内行有创机械通气患者为研究对象,从中筛选出符合VAP临床诊断标准的病例,回顾性分析VAP的病原菌分布和耐药情况。结果36例VAP患者共培养出病原菌175株,其中G^-杆菌154株,占88%,G^+球菌15株,占8.6%,真菌6株,占3.4%。位于前5位的病原菌依次为铜绿假单胞菌、嗜麦芽窄食单胞菌、鲍曼不动杆菌、洋葱伯克霍尔德菌、金黄色葡萄球菌。产超广谱β-内酰胺酶(ESBLs)细菌分离率为33.3%。G^-杆菌对常用抗菌药已表现出较高的耐药率,金黄色葡萄球菌耐药现象严重,耐甲氧西林金黄色葡萄球菌(MRSA)占66.7%,但对万古霉素、替考拉宁敏感。结论VAP主要病原菌为G^-杆菌且存在严重的耐药现象,对机械通气患者应严密监测病原菌,合理选用抗生素,加强管理,综合防治VAP。 Objective To investigate the pathogenesis and the drug-resistance of VAP in ICU to provide a reference for the clinical treatment. Methods Retrospective analysis was performed on bacterial distribution and drug-resistance in objects who receiving mechanical ventilation and diagnosing VAP in ICU of the first hospital of China Medical University from Dec 2007 to Dec 2008. Results Among 175 strains of pathogens from 36 VAP patients,the Gram-negative bacilli(GNB) occupied 88% ( 154 strains), the Gram-positive bacteria (GPB) were 8.6% ( 15 strains ), and the fungi were 3.4% (6 strains). The most common pathogens were Pseudomonas aeruginosa, Stenotrophomonas mahophilia, Acinetobacter baumannii, Burkholderia cepacia, and Staphylococcus aureus. ESBLs accounted for 33.3%. The drug resistance of GNB to antibiotics is increasing. Staphylococcus aureus had severe drug-resistance. Methicillin-resistant Staphylococcus aureus accounted for 67.7%, but was still highly susceptible to vancomycin and teicopla- nin. Conclusions The most important pathogens in VAP are the Gram- negative bacilli which drug resist- ance to antibiotics is increasing. To effectively control VAP, extensive and dynamical monitoring of VAP pathogens and rational use of antibiotics were advocated.
作者 何忠 赵洪文
出处 《临床内科杂志》 CAS 2011年第1期21-24,共4页 Journal of Clinical Internal Medicine
关键词 呼吸机相关性肺炎 病原菌 耐药性 Ventilator-associated pneumonia Pathogenic bacteria Drug resistance
  • 相关文献

参考文献13

二级参考文献74

共引文献2705

同被引文献57

  • 1叶惠芬,陈惠玲,周小棉,张晓洁.广州地区鲍曼不动杆菌产β内酰胺酶基因型调查[J].中国感染与化疗杂志,2008,8(4):307-310. 被引量:8
  • 2Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis,2005,41:848-854.
  • 3Ali SQ,Zehra A, Naqvi BS, et al. Resistance pattern of ciprofloxacin against different pathogens. Oman Med J ,2010,25:294-298.
  • 4Ibrahim EH,Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest,2000,118 : 146-155.
  • 5Torres A,Rello J. Update in community-acquired and nosocomialpneumonia 2009. Am J Respir Crit Care Med, 2010, 181 ( 8 ):782-787.
  • 6American Thoracic Society, Infectious Diseases Society of Ameri-ca. Guidelines for the management of adults with hospital-ac-quired,ventilator-associated, and healthcare-associated pneumoni-a. Am J Respir Crit Care Med, 2005 , 171(4) : 388-416.
  • 7Rice LB. The Maxwell Finland Lecture: for the duration-rationalantibiotic administration in an era of antimicrobial resistance andclostridium difficile. Clin Infect Dis ,2008 , 46(4) :491496.
  • 8Micek ST, Ward S, Fraser VJ, et al. A randomized controlled trialof an antibiotic discontinuation policy for clinically suspected vent-ilator-associated pneumonia. Chest 2004,125(5) :1791-1799.
  • 9Mandell Lionel A, Wunderink Richard G, Anzueto A, et al. Infec-tious Diseases Society of America/American Thoracic Society Con-sensus guidelines on the management of community-acquired pneu-monia in adults. Clin Infect Dis ,2007,44 (Suppl 2) :S27-S72.
  • 10Fekih Hassen M,Ayed S,Ben Sik Ali H,et al. Duration of antibiot-ic therapy for ventilator一associated pneumonia : comparison of 7 and10 days. A pilot study. Ann Fr Anesth Reanim,2009,28 (1 ) : 16-23.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部